Biotech Values

[Bickema]

CLSD - Anyone looked into or have an opinion on Clearside Biomedical?

They are developing potential therapies for eye diseases using a proprietary treatment approach where pharmacological candidates have access to the back of the eye through suprachoroidal injections.

So far they've had success in treating Uveitis with positive Phase 3 results reported in March. Will file NDA in Q418.
http://ir.clearsidebio.com/news-releases/news-release-details/clearside-biomedical-announces-positive-topline-results-pivotal

In March they raised $85 million at $13 a share. End of Q4 they had $38 million plus the $85 million raised.

Enterprise value of roughly $268 million and all their programs are wholly owned.

Upcoming phase2 data for DME in Q218.

Latest Corporate Presentation: http://ir.clearsidebio.com/static-files/3ba32269-ebf8-43de-82e0-b78a7cbb8512